Work

Efficacy and safety of liposomal anthracyclines in Phase I/II clinical trials

Year: 2004

Type: article

Source: Seminars in Oncology

DOI: 10.1053/j.seminoncol.2004.08.010

Authors: David S. Alberts, Franco M. Muggia, James Carmichael, Eric P. Winer, Mohammad Jahanzeb, Alan P. Venook, Keith M. Skubitz, Edgardo Rivera, Joseph A. Sparano, Nicholas J. Dibella, Simon J. Stewart, John J. Kavanagh, Alberto A. Gabizon

Institutions: University of Arizona, University of Arizona Cancer Center, New York University, Nottingham City Hospital, Dana-Farber Cancer Institute, University of Tennessee Health Science Center, University of Tennessee System, University of California, San Francisco, University of Minnesota, Fairview Health Services, The University of Texas MD Anderson Cancer Center, Albert Einstein College of Medicine, Rocky Mountain Cancer Centers, Charing Cross Hospital, Shaare Zedek Medical Center

Language: English

Topic: Nanoparticle-Based Drug Delivery

Subfield: Biomaterials

Field: Materials Science

Domain: Physical Sciences

SDG: Good health and well-being

Open Access status: closed

OpenAlex ID: W1964697231

FWCI: 4.153

Cites: 216

Cited by: 139

Related to: 10